Document Detail


Levosimendan in acute pulmonary embolism.
MedLine Citation:
PMID:  17933166     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Levosimendan has been used successfully in the treatment of ischaemic cardiac failure and myocardial stunning. There is growing evidence from both human and animal experiments that levosimendan has particularly favourable effects on the right ventricle. We describe a case of life-threatening pulmonary embolus supported by the use of levosimendan.
Authors:
B P Powell; D Simes
Related Documents :
8447876 - Arterial emboli of the upper extremity presenting as ischemic heart disease: case repor...
11796466 - Unilateral chronic thromboembolic pulmonary disease associated with combined inherited ...
17495056 - Cardiac metastasis: a cause of recurrent pulmonary emboli.
4062086 - Fiberoptic angioscopy: role in the diagnosis of chronic pulmonary arterial obstruction.
24368976 - Surgical treatment of ruptured renal artery aneurysm: a report of 2 cases.
3491756 - Venous digital angio-radiography: an accurate and useful technique for assessing corona...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Anaesthesia and intensive care     Volume:  35     ISSN:  0310-057X     ISO Abbreviation:  Anaesth Intensive Care     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-10-15     Completed Date:  2007-12-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0342017     Medline TA:  Anaesth Intensive Care     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  771-2     Citation Subset:  IM    
Affiliation:
Fremantle Intensive Care Unit, Fremantle Hospital, Fremantle, Western Australia, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Aged
Cardiotonic Agents / therapeutic use*
Humans
Hydrazones / therapeutic use*
Male
Pulmonary Artery
Pulmonary Embolism / drug therapy*
Pyridazines / therapeutic use*
Chemical
Reg. No./Substance:
0/Cardiotonic Agents; 0/Hydrazones; 0/Pyridazines; 131741-08-7/simendan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Early autonomic dysreflexia in acute paraplegia following anterior spinal artery thrombosis.
Next Document:  Inspiratory muscle training to enhance weaning from mechanical ventilation.